High Q Technologies and Creative Biostructure Advance Quantum EPR Research
Summarize this article with:
Insider Brief High Q Technologies and Creative Biostructure have formed a partnership to support broader adoption of EPR spectroscopy in pharmaceutical and biotechnology research. The collaboration combines High Q Technologies’ FATHOM quantum EPR spectroscopy platform with Creative Biostructure’s expertise in experimental design, scientific consultation, and workflow support. The companies aim to help researchers study protein dynamics, molecular motion, and complex biological systems involved in drug discovery. PRESS RELEASE — High Q Technologies, a developer of quantum computing-ready electron paramagnetic resonance (EPR) spectroscopy systems, and Creative Biostructure, a contract research organization in structural biology, today announce a strategic partnership to support wider adoption wide range of EPR spectroscopy for the study of protein dynamics in pharmaceutical and biotechnology research. EPR spectroscopy is increasingly relevant as drug discovery shifts toward disordered, flexible, disease-specific protein systems that cannot be fully understood by static structural methods alone. However, widespread adoption of RPE has always been limited by the complexity of instruments and workflows, as well as the need for specific technical expertise in experimental design and data interpretation. Leveraging quantum sensor technology, RPE FATHOM® met these challenges. By providing unique measurements of long distances, the RPE FATHOM® allows researchers to probe the conformational sets and molecular movements involved in today’s most complex health disorders, where intrinsic disorder, aggregation, and dynamic intermediates drive pathology. Through this collaboration, Creative Biostructure will provide scientific consultation, experimental design support and workflow guidance to companies implementing the RPE FATHOM spectroscopy platform® from High Q Technologies. “Drug discovery is increasingly focused on understanding the behavior of proteins in motion”, says Don Carkner, managing director of High Q Technologies. “With FATHOM®, quantum EPR spectroscopy helps study these dynamic systems, and through this partnership with Creative Biostructure, we are making these capabilities more accessible within structural biology and drug discovery workflows. “ Tony Zhang, chief scientist at Creative Biostructure, says: Modern structural biology is moving toward integrating synergistic techniques to understand complex biomolecular systems. EPR spectroscopy adds an important layer of dynamic information that complements methods such as cryo-electron microscopy, NMR spectroscopy and computational modeling. Companies interested in Creative Biostructure’s RPE spectroscopy services or additional information are encouraged to consult https://www.creative-biostructure.com/quantum-epr-spectroscopy-platform.htm.
Mohib Ur Rehman LinkedIn Mohib has been tech-savvy since his teens, always tearing things apart to see how they worked. His curiosity for cybersecurity and privacy evolved from tinkering with code and hardware to writing about the hidden layers of digital life. Now, he brings that same analytical curiosity to quantum technologies, exploring how they will shape the next frontier of computing. Share this article: